Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.

about

The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart

P2860

Q60927794-13f1b45a-4c0b-ada9-2c00-79e1207c0889

P2860

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.

Item

http://www.wikidata.org/entity/Q47299769

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@en

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@nl

type

Item

label

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@en

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@nl

prefLabel

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@en

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@nl

P1476

Sodium Valproate, a Histone De ...... or Transient Ischemic Attack.

@en

P2093

Charles D A Wolfe

http://www.w3.org/2001/XMLSchema#string

Hugh S Markus

http://www.w3.org/2001/XMLSchema#string

Qilong Yi

http://www.w3.org/2001/XMLSchema#string

Rebecca L Brookes

http://www.w3.org/2001/XMLSchema#string

Siobhan Crichton

http://www.w3.org/2001/XMLSchema#string

P2860

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

Histone deacetylase inhibitors: Potential in cancer therapy

Is sodium valproate, an HDAC inhibitor, associated with reduced risk of stroke and myocardial infarction? A nested case-control study

Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.

Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke.

Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.

Estimates of outcomes up to ten years after stroke: analysis from the prospective South London Stroke Register

Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis.

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial.

Large-scale association analysis identifies new risk loci for coronary artery disease

P304

54-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/STROKEAHA.117.016674

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Graeme J. Hankey

Linxin Li

Peter M. Rothwell

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29247141

http://www.w3.org/2001/XMLSchema#string

P932

5753817

http://www.w3.org/2001/XMLSchema#string

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.

about

P2860

P2860

Sodium Valproate, a Histone Deacetylase Inhibitor, Is Associated With Reduced Stroke Risk After Previous Ischemic Stroke or Transient Ischemic Attack.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932